Ginkgo biloba for cognitive impairment and dementia

This is a protocol for a Cochrane Review (intervention). The objectives are as follows:

To assess the efficacy and safety of Ginkgo for the treatment of people with diagnoses of cognitive impairment or dementia.

This is a protocol.

Health topics:

Mental health > Dementia & cognition > Interventions aimed at interrupting disease processes

Neurology > Dementia & cognition > Treatment aimed at interrupting disease processes

Published:

2 July 2020

Authors:

Wieland LS, Feinberg TM., Ludeman E, Prasad NK, Amri H

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Wieland LS, Feinberg TM., Ludeman E, Prasad NK, Amri H. Ginkgo biloba for cognitive impairment and dementia (Protocol). Cochrane Database of Systematic Reviews 2020, Issue 7. Art. No.: CD013661. DOI: 10.1002/14651858.CD013661.